APTN · Adaptin Bio, Inc.
$6.27
At close · Aug 19
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Management has evaluated the Company's operating plan against its existing cash and determined that substantial doubt exists about the Company's ability to support its operations and fund its obligations for the next twelve months from the date of issuance of these condensed consolidated financial statements.”View the 10-Q filed Aug 13, 2026
Market Cap
$57.89M
Shares
9.23M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2026-06-22 | Amendment | Biotechnology | $4,000,000 | $1,912,000 | 06b |
| 2026-03-23 | Amendment | Biotechnology | $4,000,000 | $1,652,000 | 06b |
| 2026-02-20 | Amendment | Biotechnology | $4,000,000 | $1,297,000 | 06b |
| 2026-01-05 | New | Biotechnology | $4,000,000 | $1,000,000 | 06b |
| 2025-02-26 | New | Biotechnology | $23,375,010 | $13,077,849 | 06b |
Showing 1–5 of 5 filings